CELL — Phenomex Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall Cap

Annual balance sheet for Phenomex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	99.6	81	233	178	133
Net Total Accounts Receivable
Net Total Receivables	12.4	14.6	14.2	27.7	19.8
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	119	105	266	231	177
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	14.1	24.3	31.3	54.1	47.2
Long Term Notes Receivable
Other Long Term Assets
Total Assets	134	131	300	287	226
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15.3	24.9	29	32.8	45.5
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	36.2	47.2	54.9	79	84
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	97.6	83.8	245	208	142
Total Liabilities & Shareholders' Equity	134	131	300	287	226
Total Common Shares Outstanding